Results 81 to 90 of about 174,156 (175)

Kinase mutant Btk results in atypical X‐linked agammaglobulinaemia phenotype

Clinical and Experimental Immunology, 2000
H. B. Gaspar, M. Ferrando, I. Caragol, M. Hernandez, J. Bertran, X. D. gracia, T. Lester, Christine Kinnon, E. Ashton, Teresa Espanol   +9 more
semanticscholar   +1 more source

Molecular insight on the role of the phosphoinositide PIP3 in regulating the protein kinases Akt, PDK1, and BTK. [PDF]

Biochem Soc Trans
Shaw AL, Burke JE.
europepmc   +1 more source

Membrane-dependent assembly of Bruton's tyrosine kinase mediated by the Proline-rich region and SH3 domain. [PDF]

Protein Sci
Fenton AD, Chung JK.
europepmc   +1 more source

Bruton's Tyrosine Kinase (BTK) Is Present in Normal Platelets, and Its Absence Identifies Patients with X-Linked Agammaglobulinemia (XLA) and Carrier Females

British Journal of Haematology, 1999
C. Watanabe, T. Futatani, Y. Baba, S. Tsukada, A. Oda, H. Ochs   +5 more
semanticscholar   +1 more source

Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes. [PDF]

J Am Chem Soc
Pergu R, Sreekanth V, Kokkonda P, Lai S, Tiwari PK, Singh S, Kawai J, Singha S, Tian W, Thimaradka V, Siriwongsup S, Tran K, Choudhary A.   +12 more
europepmc   +1 more source

Expanded CD16⁺CD56⁺Granzyme B⁺ NK like CD8⁺ T cells an off target effect of bruton's tyrosine kinase inhibitors in Waldenström macroglobulinemia. [PDF]

Sci Rep
Hastak P, Phetsouphanh C, Zhang ZH, Bull RA, Shrestha LB, Klemm V, Louie R, Luciani F, Munier CML, Hoppé AC, Keoshkerian E, Beaton B, Rankin K, Wong A, Trotman J, Kelleher AD, Sasson SC.   +16 more
europepmc   +1 more source

Importance of B cell co‐stimulation in CD4+ T cell differentiation: X‐linked agammaglobulinaemia, a human model

Clinical and Experimental Immunology, 2011
H. Martini, H. Martini, V. Enright, M. Perro, S. Workman, Jennifer Birmelin, E. Giorda, Isabella Quinti, V. Lougaris, Manuela Baronio, K. Warnatz, B. Grimbacher   +11 more
semanticscholar   +1 more source

Strongyloides stercoralis infection in a DLBCL patient treated with rituximab and BTK inhibitor: A case report and literature review. [PDF]

Medicine (Baltimore)
Liu W, Wang Z, Wu H, Zeng L, Cai N, Zhuang W, Guo J.   +6 more
europepmc   +1 more source

Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials. [PDF]

Ann Hematol
Mahadevia H, Ponvilawan B, Shrestha A.
europepmc   +1 more source

Cost impact of Bruton's tyrosine kinase inhibitor selection in Medicare patients with chronic lymphocytic leukemia. [PDF]

J Comp Eff Res
Kittai AS, Patel DA, Shafrin J, Zawadzki N, Shetty VS, Barqawi YK, Rhodes JM.   +6 more
europepmc   +1 more source